Currently out of the existing stock ratings of Kyle Bauser, 35 are a BUY (92.11%), 3 are a HOLD (7.89%).

Kyle Bauser

Work Performance Price Targets & Ratings Chart

Analyst Kyle Bauser, currently employed at ROTH, carries an average stock price target met ratio of 57.33% that have a potential upside of 38.16% achieved within 122 days. Previously, Kyle Bauser worked at LAKE STREET.

Kyle Bauser’s has documented 79 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on APYX, Apyx Medical at 16-Dec-2025.

Wall Street Analyst Kyle Bauser

Analyst best performing recommendations are on CEMI (CHEMBIO DIAGNOSTICS).
The best stock recommendation documented was for CLPT (CLEARPOINT NEURO) at 8/8/2024. The price target of $10.5 was fulfilled within 7 days with a profit of $1.44 (15.89%) receiving and performance score of 22.71.

Average potential price target upside

of $12.89 (21.9%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $8.74 (82.19%) on ELMD (ELECTROMED).
of $7.58 (116.32%) on OPRX (OPTIMIZERX CORP).

CEMI Chembio Diagnostics APYX Apyx Medical BIOL BIOLASE SIEN Sientra PFMT Performant Financial UFPT UFP Technologies ELMD Electromed STRM Streamline Health Solutions VREX Varex Imaging Corp SPOK Spok Holdings CLPT Clearpoint Neuro INSP Inspire Medical Systems MYO Myomo OPRX OPTIMIZERx Corp TCMD Tactile Systems Technology

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score